Martin Amark
Health & Wealth #19 | Live with Martin Åmark, Xbrane Biopharma | Global Forum 2025
A Health & Wealth podcast episode featuring Martin Åmark, CEO of Xbrane Biopharma led by BioStock's CEO Jonas Söderström....
Video
Why are biosimilars an interesting market? – Xbrane's CEO answers
Developing biosimilars of successful biological medicines...
Intervju
Video
Strong premiere for Executive Insights in Stockholm
How should life science companies capture investor interest in...
Xbrane raises SEK 146 million in private placement
After the market closed yesterday, the biosimilars company Xbrane announced...
Scandinavia well represented at JP Morgan Week in San Francisco
Today the JP Morgan Healthcare Conference begins in San...
Inhalers, immunomodulators, mitochondrial medicine and biosimilars at BLSS 2019
The fifth round of presentations at the BioStock Life Science Summit...
Issue to bring market within reach for Xbrane Biopharma
Xbrane Biopharma is a biosimilars company whose lead candidate,...
Xbrane Biopharma raises SEK 238 million in crucial development phase
Xbrane Biopharma has initiated phase III clinical trials with...
CEO interview and presentation with Xbrane Biopharma from BioStock Live
On Monday, March 25, Xbrane Biopharma's rights issue will close...
Xbrane Biopharma raises SEK 59 million for final clinical phase
Xbrane Biopharma enters pivotal Phase III clinical trials with...